CS logo
small CS logo
Mary Rutan Hospital

Bellefontaine, Ohio, United States
Hospital in Bellefontaine, Ohio
205 E Palmer Rd, Bellefontaine, OH 43311

About Mary Rutan Hospital


"Recognized at a national level for the quality care we're providing, Mary Rutan Hospital is ready to deliver the best care to you and your family. For more than 100 years, Mary Rutan Hospital has continuously improved and developed services to best meet your needs."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
45
Alliance for Clinical Trials in Oncology
24
SWOG Cancer Research Network
23
NSABP Foundation Inc
5
ECOG-ACRIN Cancer Research Group
3
Eastern Cooperative Oncology Group
2
North Central Cancer Treatment Group
1
Radiation Therapy Oncology Group
1
Total Rows: 8

Clinical Trials at Mary Rutan Hospital


During the past decade, Mary Rutan Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 79 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
2004-03-01
2012-08-01
Completed
110
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
2004-04-01
2018-10-01
Completed
695

Rows per page:

1–100 of 104

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Mary Rutan Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "SWOG Cancer Research Network" with 23 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Rutan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 45National CancerInstitute (NCI): 45Alliance for ClinicalTrials in Oncology: 24Alliance for ClinicalTrials in Oncology: 24SWOG Cancer ResearchNetwork: 23SWOG Cancer ResearchNetwork: 23NSABP Foundation Inc: 5NSABP Foundation Inc: 5ECOG-ACRIN CancerResearch Group: 3ECOG-ACRIN CancerResearch Group: 3Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2North Central CancerTreatment Group: 1North Central CancerTreatment Group: 1Radiation TherapyOncology Group: 1Radiation TherapyOncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 59National CancerInstitute (NCI): 59Cancer and LeukemiaGroup B: 9Cancer and LeukemiaGroup B: 9NCIC Clinical Trials Group: 9NCIC Clinical Trials Group: 9NRG Oncology: 7NRG Oncology: 7SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Eastern CooperativeOncology Group: 6Eastern CooperativeOncology Group: 6North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5American College ofSurgeons: 1American College ofSurgeons: 1Children's Oncology Group: 1Children's Oncology Group: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1

Clinical Trials Conditions at Mary Rutan Hospital


According to Clinical.Site data, the most researched conditions in "Mary Rutan Hospital" are "Breast Cancer" (15 trials), "Lymphoma" (10 trials), "Lung Cancer" (9 trials), "Leukemia" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Mary Rutan Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Mary Rutan Hospital


Most popular intervention types in "Mary Rutan Hospital" are "Drug" (82 trials), "Other" (58 trials), "Biological" (46 trials), "Procedure" (11 trials) and "Radiation" (8 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Bevacizumab" (18 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (12 trials) and "placebo" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Mary Rutan Hospital


The vast majority of trials in "Mary Rutan Hospital" are 83 trials for "All" genders, 20 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Mary Rutan Hospital


Currently, there are NaN active trials in "Mary Rutan Hospital". undefined are not yet recruiting, undefined are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Mary Rutan Hospital, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Mary Rutan Hospital, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 56Phase 3: 56Phase 2: 37Phase 2: 37Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 67Completed: 67Active, not recruiting: 27Active, not recruiting: 27Terminated: 10Terminated: 10